Researches also indicated that UCA1 enhanced CDDP resistance in ovarian cancer 19 and bladder cancer 20, and increased 5‐fluorouracil resistance in colorectal cancer 11, indicating the critical role of UCA1 in chemoresistance. Here, UCA1 is linked to ovarian carcinoma.